Lindmark; Bertil
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lindmark; Bertil.The latest application filed is for "method of treatment using il-13r antibody".
- Lindmark; Bertil - Singapore SG
- Lindmark; Bertil - Lund SE
| Patent | Date |
|---|---|
| Cancer therapy Grant 11,382,903 - Lindmark , et al. July 12, 2 | 2022-07-12 |
| Cancer therapy Grant 11,311,548 - Lindmark , et al. April 26, 2 | 2022-04-26 |
| Combination therapy comprising Varlitinib and an anticancer agent Grant 10,849,899 - Lindmark , et al. December 1, 2 | 2020-12-01 |
| Varlitinib for use in the treatment of resistant or refractory cancer Grant 10,682,353 - Lindmark , et al. | 2020-06-16 |
| Method Of Treatment Using Il-13r Antibody App 20200165347 - Lindmark; Bertil ; et al. | 2020-05-28 |
| Combination Therapy Comprising Varlitinib and an Anticancer Agent App 20200009144 - Lindmark; Bertil ; et al. | 2020-01-09 |
| Maintenance Therapy for the Treatment of Cancer App 20190321365 - Lindmark; Bertil | 2019-10-24 |
| Combination therapy comprising varlitinib and an anticancer agent Grant 10,357,494 - Lindmark , et al. July 23, 2 | 2019-07-23 |
| Cancer Therapy App 20190151326 - Lindmark; Bertil ; et al. | 2019-05-23 |
| Method of Treating Liver Cancer App 20190134034 - Ooi; Lisa ; et al. | 2019-05-09 |
| Treatment of Biliary Duct Cancer App 20190117655 - Lindmark; Bertil ; et al. | 2019-04-25 |
| Cancer Therapy App 20190038610 - Lindmark; Bertil ; et al. | 2019-02-07 |
| Treatment of Biliary Duct Cancer App 20180353510 - Lindmark; Bertil ; et al. | 2018-12-13 |
| A Combination Therapy Comprising Varlitinib and an Anticancer Agent App 20180256578 - Lindmark; Bertil ; et al. | 2018-09-13 |
| Varlitinib for Use in the Treatment of Resistant or Refractory Cancer App 20180243302 - Lindmark; Bertil ; et al. | 2018-08-30 |
| Combinations of Statins with Bronchodilators App 20080004247 - Lindmark; Bertil ; et al. | 2008-01-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 